Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,424.85 162.29 1.00%
S&P 500 1,862.31 19.33 1.05%
NASDAQ 4,086.22 52.06 1.29%
Ticker Volume Price Price Delta
STOXX 50 3,139.26 47.74 1.54%
FTSE 100 6,584.17 42.56 0.65%
DAX 9,317.82 144.11 1.57%
Ticker Volume Price Price Delta
NIKKEI 14,405.23 -12.45 -0.09%
TOPIX 1,166.47 -0.08 -0.01%
HANG SENG 22,757.31 61.30 0.27%

IRSH: Elan Corporation PLC: Elan Announces Filing of Annual Report on Form 20-F for Year Ended December 31, 2012



  IRSH: Elan Corporation PLC: Elan Announces Filing of Annual Report on Form
  20-F for Year Ended December 31, 2012

UK Regulatory Announcement

DUBLIN

Elan Corporation, plc (NYSE: ELN) today announced the filing of its Annual
Report on Form 20-F for the fiscal year ended December 31, 2012. The Form 20-F
is available on Elan's website at http://www.elan.com. Elan will provide to
all holders of Elan securities, upon request and free of charge, a hard copy
of our complete audited financial statements included in our Form 20-F.

About Elan Corporation, plc

Elan Corporation, plc is a biotechnology company, headquartered in Ireland,
committed to making a difference in the lives of patients and their families
by dedicating itself to bringing innovations in science to fill significant
unmet medical needs that continue to exist around the world. Elan shares trade
on the New York and Irish Stock Exchanges. For additional information about
the Elan, please visit http://www.elan.com.

Elan Corporation
Investor Relations:
Chris Burns, 800-252-3526
David Marshall, 353-1-709-4444
or
Media Relations:
Emer Reynolds, + 353-1-709-4022
Jonathan Birt, +44-751-559-7858

Contact:

Elan Corporation PLC
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement